CPC A61K 39/12 (2013.01) [C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C12N 7/00 (2013.01); A61K 2039/507 (2013.01); A61K 2039/53 (2013.01); C12N 2710/20034 (2013.01)] | 21 Claims |
1. A method for treating human papillomavirus (HPV)-induced cancer in a subject in need thereof, comprising administering an HPV vaccine and a checkpoint inhibitor agent to the subject, over a common period of time, for generating a therapeutic effect greater than either the HPV vaccine or checkpoint inhibitor alone when used as monotherapy.
|